当前位置: 首页 >> 检索结果
601. A cost consequences analysis of local corticosteroid injection and physiotherapy for the treatment of new episodes of unilateral shoulder pain in primary care.
作者: M James.;E A Stokes.;E Thomas.;K Dziedzic.;E M Hay.
来源: Rheumatology (Oxford). 2005年44卷11期1447-51页
Local steroid injections and community-based physiotherapy have been shown to be of similar benefit for treating shoulder pain presenting to primary care. This paper presents a cost consequences analysis of a prospective economic evaluation, conducted alongside a randomized clinical trial (RCT) of corticosteroid injections versus physiotherapy for new episodes of unilateral shoulder pain, to determine the economic implications of injection versus physiotherapy.
602. Persistent reduction of spinal inflammation as assessed by magnetic resonance imaging in patients with ankylosing spondylitis after 2 yrs of treatment with the anti-tumour necrosis factor agent infliximab.
作者: J Sieper.;X Baraliakos.;J Listing.;J Brandt.;H Haibel.;M Rudwaleit.;J Braun.
来源: Rheumatology (Oxford). 2005年44卷12期1525-30页
Patients with ankylosing spondylitis (AS) benefit from anti-TNF therapy both on a clinical basis and as depicted by magnetic resonance imaging (MRI). It is not known whether spinal inflammation remains suppressed over time. Our objective was to assess spinal inflammation by MRI in AS patients after 2 yr of continuous infliximab treatment.
603. A multicentre randomized controlled trial of epidural corticosteroid injections for sciatica: the WEST study.
作者: N K Arden.;C Price.;I Reading.;J Stubbing.;J Hazelgrove.;C Dunne.;M Michel.;P Rogers.;C Cooper.; .
来源: Rheumatology (Oxford). 2005年44卷11期1399-406页
To determine the effectiveness and predictors of response to lumbar epidural corticosteroid injections (ESI) in patients with sciatica. We performed a 12-month, multicentre, double-blind, randomized, placebo-controlled, parallel-group trial in four secondary pain-care clinics in the Wessex Region.
604. A randomized clinical trial of an individualized home-based exercise programme for women with fibromyalgia.
作者: D Da Costa.;M Abrahamowicz.;I Lowensteyn.;S Bernatsky.;M Dritsa.;M-A Fitzcharles.;P L Dobkin.
来源: Rheumatology (Oxford). 2005年44卷11期1422-7页
To determine the efficacy of a 12-week individualized home-based exercise programme on physical functioning, pain severity and psychological distress for women with fibromyalgia (FM).
605. What factors influence functional ability in patients with rheumatoid arthritis. Do they alter over time?
作者: M J Plant.;M M O'Sullivan.;P A Lewis.;J P Camilleri.;E C Coles.;J D Jessop.
来源: Rheumatology (Oxford). 2005年44卷9期1181-5页
To describe the changes in functional ability (FA) taking place over 5 yr in patients with rheumatoid arthritis (RA) starting disease-modifying anti-rheumatic drug (DMARD) therapy, to investigate the factors having most influence upon FA and to compare these factors at baseline and after 5 yr of treatment.
606. The perceptions of final year medical students in rheumatology workshops when delivered by a consultant and a nurse clinical educator.
To determine whether final year medical students' perceptions of teaching workshops delivered by a consultant rheumatologist are similar those of the same workshops delivered by an experienced nurse clinical educator (NCE).
607. Persistent clinical response to the anti-TNF-alpha antibody infliximab in patients with ankylosing spondylitis over 3 years.
作者: J Braun.;X Baraliakos.;J Brandt.;J Listing.;A Zink.;R Alten.;G Burmester.;E Gromnica-Ihle.;H Kellner.;M Schneider.;H Sörensen.;H Zeidler.;J Sieper.
来源: Rheumatology (Oxford). 2005年44卷5期670-6页
Infliximab, a monoclonal antibody against tumour necrosis factor alpha (TNF-alpha), is approved in Europe for the treatment of patients with active ankylosing spondylitis (AS) who have responded inadequately to conventional therapy. This report provides analyses from a 3-yr extension study, as a follow-up to both the 1- and 2-yr open label extensions of the original 3-month randomized controlled trial of infliximab in patients with AS.
608. A prospective study of the long-term efficacy of local methyl prednisolone acetate injection in the management of mild carpal tunnel syndrome.
作者: V Agarwal.;R Singh.;A Sachdev.; Wiclaff.;S Shekhar.;D Goel.
来源: Rheumatology (Oxford). 2005年44卷5期647-50页
Local glucocorticoid injections are used to treat carpal tunnel syndrome (CTS). However, this treatment is associated with frequent relapses. An important limitation of studies with higher relapse rates is that no attempt has been made to identify patients with mild or severe disease. We evaluated the efficacy of local glucocorticoid injection in patients with mild CTS.
610. Moderately intensive exercise in a temperate pool for patients with rheumatoid arthritis: a randomized controlled study.
The aim of this study was to evaluate the effects of moderately intensive pool exercise therapy on patients with rheumatoid arthritis (RA).
611. Manual therapy in osteoarthritis of the hip: outcome in subgroups of patients.
作者: H L Hoeksma.;J Dekker.;H K Ronday.;F C Breedveld.;C H M Van den Ende.
来源: Rheumatology (Oxford). 2005年44卷4期461-4页
To investigate whether manual therapy has particular benefit in subgroups of patients defined on the basis of hip function, range of joint motion, pain and radiological deterioration.
612. Spa treatment for primary fibromyalgia syndrome: a combination of thalassotherapy, exercise and patient education improves symptoms and quality of life.
作者: T R Zijlstra.;M A F J van de Laar.;H J Bernelot Moens.;E Taal.;L Zakraoui.;J J Rasker.
来源: Rheumatology (Oxford). 2005年44卷4期539-46页
To study the effect of a combination of thalassotherapy, exercise and patient education in people with fibromyalgia.
613. Effects of once-weekly oral alendronate on bone in children on glucocorticoid treatment.
作者: S Rudge.;S Hailwood.;A Horne.;J Lucas.;F Wu.;T Cundy.
来源: Rheumatology (Oxford). 2005年44卷6期813-8页
To determine the effects of once-weekly oral alendronate on indices of bone size, density and resorption in children with chronic illness being treated with glucocorticoids.
614. The influence of a polymorphism at position -857 of the tumour necrosis factor alpha gene on clinical response to etanercept therapy in rheumatoid arthritis.
We aimed to test whether polymorphisms in the etanercept target genes TNFA and LTA are associated with clinical responses to etanercept therapy in RA patients.
615. A randomized controlled trial of intra-articular triamcinolone and/or physiotherapy in shoulder capsulitis.
作者: I Ryans.;A Montgomery.;R Galway.;W G Kernohan.;R McKane.
来源: Rheumatology (Oxford). 2005年44卷4期529-35页
To assess the effectiveness of intra-articular triamcinolone injection and physiotherapy singly or combined in the treatment of adhesive capsulitis of the shoulder.
616. Long-term efficacy and safety of etanercept after readministration in patients with active ankylosing spondylitis.
作者: J Brandt.;J Listing.;H Haibel.;H Sörensen.;A Schwebig.;M Rudwaleit.;J Sieper.;J Braun.
来源: Rheumatology (Oxford). 2005年44卷3期342-8页
Treatment of ankylosing spondylitis (AS) with the tumour necrosis factor alpha (TNF-alpha) receptor fusion protein etanercept has shown efficacy in patients with active disease in randomized controlled trials (RCTs) for limited periods. The objective of the study was to assess the long-term efficacy and safety of etanercept over 1 yr, including discontinuation and readministration.
617. Treatment of active psoriatic arthritis with the PPARgamma ligand pioglitazone: an open-label pilot study.
作者: T Bongartz.;B Coras.;T Vogt.;J Schölmerich.;U Müller-Ladner.
来源: Rheumatology (Oxford). 2005年44卷1期126-9页
Psoriatic arthritis (PsA) is an inflammatory joint disease, in which early neovascularization of affected skin and synovial tissue represents an important pathogenetic step in the disease process. Activation of the peroxisome proliferator activated receptor gamma (PPARgamma) showed anti-inflammatory effects in several in vitro and in vivo models (e.g. collagen-induced arthritis) by inhibition of angiogenesis and suppression of proinflammatory cytokines. Therefore, we studied the use of pioglitazone, a PPARgamma agonist originally developed for the treatment of diabetes, in patients with PsA.
618. Debridement of plantar callosities in rheumatoid arthritis: a randomized controlled trial.
作者: H J Davys.;D E Turner.;P S Helliwell.;P G Conaghan.;P Emery.;J Woodburn.
来源: Rheumatology (Oxford). 2005年44卷2期207-10页
To compare forefoot pain, pressure and function before and after normal and sham callus treatment in rheumatoid arthritis (RA).
619. Efficacy of UVA-1 cold light as an adjuvant therapy for systemic lupus erythematosus.
作者: M C A Polderman.;S le Cessie.;T W J Huizinga.;S Pavel.
来源: Rheumatology (Oxford). 2004年43卷11期1402-4页
The assessment of the efficacy of therapy of patients with moderately active systemic lupus erythematosus (SLE) with low doses of UVA-1 cold light.
620. Topical tacrolimus therapy of resistant cutaneous lesions in lupus erythematosus: a possible alternative.
作者: C E Lampropoulos.;S Sangle.;P Harrison.;G R V Hughes.;D P D'Cruz.
来源: Rheumatology (Oxford). 2004年43卷11期1383-5页
To determine the efficacy of tacrolimus ointment 0.1% on resistant cutaneous lesions in patients with lupus erythematosus.
|